Thyroglobulin Antibody (TgAb) Positive is an Independent Risk Factor for Lymph Node Metastasis in Patients with Differentiated Thyroid Carcinoma

References

• Sung H, Ferlay J, Siegel RL. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Cheng F, Xiao J, Shao C, et al. Burden of thyroid cancer from 1990 to 2019 and projections of incidence and mortality until 2039 in China: findings from global burden of disease study. Front Endocrinol. 2021;12:738213. doi:10.3389/fendo.2021.738213
   PubMed Web of Science ®Google Scholar
• Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M. Update on fundamental mechanisms of thyroid cancer. Front Endocrinol. 2020;11:102. doi:10.3389/fendo.2020.00102
   PubMed Web of Science ®Google Scholar
• Lee K, Anastasopoulou C, Chandran C, Cassaro S. Thyroid Cancer. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2023. PMID: 29083690.
   Google Scholar
• Tam S, Boonsripitayanon M, Amit M, et al. Survival in differentiated thyroid cancer: comparing the AJCC cancer staging seventh and Eighth Editions. Thyroid. 2018;28(10):1301–1310. doi:10.1089/thy.2017.0572
   PubMed Web of Science ®Google Scholar
• Cracchiolo JR, Wong RJ. Management of the lateral neck in well differentiated thyroid cancer. Eur J Surg Oncol. 2018;44(3):332–337. doi:10.1016/j.ejso.2017.06.004
   PubMed Web of Science ®Google Scholar
• Zhi J, Wu Y, Hu L, et al. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma. Int J Clin Oncol. 2020;25(1):59–66. doi:10.1007/s10147-019-01522-x
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang Y, Zhao J, et al. Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis with ARMS PCR. Pathol Res Pract. 2019;215(4):761–765. doi:10.1016/j.prp.2019.01.006
   PubMed Web of Science ®Google Scholar
• Alsubaie KM, Alsubaie HM, Alzahrani FR. Prophylactic central neck dissection for clinically node-negative papillary thyroid carcinoma. Laryngoscope. 2022;132(6):1320–1328. doi:10.1002/lary.29912
   PubMed Web of Science ®Google Scholar
• Asimakopoulos P, Nixon IJ, Shaha AR. Differentiated and medullary thyroid cancer: surgical management of cervical lymph nodes. Clin Oncol. 2017;29(5):283–289. doi:10.1016/j.clon.2017.01.001
   Web of Science ®Google Scholar
• Soh SB, Aw TC. Laboratory testing in thyroid conditions - pitfalls and clinical utility. Ann Lab Med. 2019;39(1):3–14. doi:10.3343/alm.2019.39.1.3
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao C, Zhao K, et al. Glycosylation of Anti-Thyroglobulin IgG1 and IgG4 subclasses in thyroid diseases. Eur Thyroid J. 2021;10(2):114–124. doi:10.1159/000507699
   PubMed Web of Science ®Google Scholar
• Spencer CA. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab. 2011;96(12):3615–3627. doi:10.1210/jc.2011-1740
   PubMed Web of Science ®Google Scholar
• Min Y, Huang Y, Wei M, et al. Preoperatively predicting the central lymph node metastasis for papillary thyroid cancer patients with hashimoto’s thyroiditis. Front Endocrinol. 2021;12:713475. doi:10.3389/fendo.2021.713475
   PubMed Web of Science ®Google Scholar
• Li L, Shan T, Sun X, et al. Positive thyroid peroxidase antibody and thyroglobulin antibody are associated with better clinicopathologic features of papillary thyroid cancer. Endocr Pract. 2021;27(4):306–311. doi:10.1016/j.eprac.2020.10.017
   PubMed Web of Science ®Google Scholar
• Wu X, Liu Y, Li K, et al. Predictive Value of FNA-Tg and TgAb in cervical lymph node metastasis of papillary thyroid carcinoma. Technol Cancer Res Treat. 2022;21:15330338221127605. doi:10.1177/15330338221127605
   Web of Science ®Google Scholar
• Zhou Y, Sun Z, Zhou Y, et al. Thyroid antibody status exerts insignificant effect on lymph node metastasis of thyroid cancer. Transl Cancer Res. 2020;9(10):6423–6430. doi:10.21037/tcr-20-1941
   PubMed Web of Science ®Google Scholar
• Jo K, Lim DJ. Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer. Korean J Intern Med. 2018;33(6):1050–1057. doi:10.3904/kjim.2018.289
   PubMed Web of Science ®Google Scholar
• Lai Y, Gu Y, Yu M, Deng J. Younger Than 55 years old and BRAF V600E mutation are risk factors for lymph node metastasis in papillary thyroid carcinomas ≤1.0 cm but not in >1.0 cm. Int J Gen Med. 2023;16:1403–1414. doi:10.2147/IJGM.S408588
   PubMed Web of Science ®Google Scholar
• So YK, Kim MJ, Kim S, Son YI. Lateral lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis for prevalence, risk factors, and location. Int J Surg. 2018;50:94–103. doi:10.1016/j.ijsu.2017.12.029
   PubMed Web of Science ®Google Scholar
• Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338(5):297–306. doi:10.1056/NEJM199801293380506
   PubMed Web of Science ®Google Scholar
• Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol. 2012;269(3):1013–1017. doi:10.1007/s00405-011-1732-6
   PubMed Web of Science ®Google Scholar
• Lee ZJO, Eslick GD, Edirimanne S. Investigating antithyroglobulin antibody as a prognostic marker for differentiated thyroid cancer: a meta-analysis and systematic review. Thyroid. 2020;30(11):1601–1612. doi:10.1089/thy.2019.0368
   PubMed Web of Science ®Google Scholar
• Wassner AJ, Della Vecchia M, Jarolim P, Feldman HA, Huang SA. Prevalence and significance of thyroglobulin antibodies in pediatric thyroid cancer. J Clin Endocrinol Metab. 2017;102(9):3146–3153. doi:10.1210/jc.2017-00286
   PubMed Web of Science ®Google Scholar
• Karatzas T, Vasileiadis I, Zapanti E, Charitoudis G, Karakostas E, Boutzios G. Thyroglobulin antibodies as a potential predictive marker of papillary thyroid carcinoma in patients with indeterminate cytology. Am J Surg. 2016;212(5):946–952. doi:10.1016/j.amjsurg.2015.12.030
   PubMed Web of Science ®Google Scholar
• Giagourta I, Evangelopoulou C, Papaioannou G, et al. Autoimmune thyroiditis in benign and malignant thyroid nodules: 16-year results. Head Neck. 2014;36(4):531–535. doi:10.1002/hed.23331
   PubMed Web of Science ®Google Scholar
• Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med. 1996;335(2):99–107. doi:10.1056/NEJM199607113350206
   PubMed Web of Science ®Google Scholar
• Jara SM, Carson KA, Pai SI, et al. The relationship between chronic lymphocytic thyroiditis and central neck lymph node metastasis in North American patients with papillary thyroid carcinoma. Surgery. 2013;154(6):1272–1280. doi:10.1016/j.surg.2013.07.021
   PubMed Web of Science ®Google Scholar
• Scheffel RS, Dora JM, Maia AL. BRAF mutations in thyroid cancer. Curr Opin Oncol. 2022;34(1):9–18. doi:10.1097/CCO.0000000000000797
   PubMed Web of Science ®Google Scholar
• Semsar-Kazerooni K, Morand GB, Payne AE, et al. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer. J Otolaryngol Head Neck Surg. 2022;51(1):9. doi:10.1186/s40463-022-00559-9
   PubMed Web of Science ®Google Scholar
• Kim SK, Lee JH, Woo JW, et al. BRAF V600E mutation: differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma. Head Neck. 2016;38:E1203–E1209. doi:10.1002/hed.24192
   PubMed Web of Science ®Google Scholar
• Tao Y, Wang F, Shen X, et al. BRAF V600E status sharply differentiates lymph node metastasis-associated mortality risk in papillary thyroid cancer. J Clin Endocrinol Metab. 2021;106(11):3228–3238. doi:10.1210/clinem/dgab286
   PubMed Web of Science ®Google Scholar
• Wahid MHA, Almudhafar RH. Comparative BRAF V600E immunohistochemical expression in differentiated thyroid tumors with papillary features. J Med Life. 2022;15(4):520–525. doi:10.25122/jml-2021-0415
   PubMedGoogle Scholar
• Gao J, Ma XP, Deng FS, Jiang L, Jia WD, Li M. Associations of the BRAF V600E Mutation and PAQR3 protein expression with papillary thyroid carcinoma clinicopathological features. Pathol Oncol Res. 2020;26(3):1833–1841. doi:10.1007/s12253-019-00779-x
   PubMed Web of Science ®Google Scholar
• Danilovic DL, Lima EU, Domingues RB, Brandão LG, Hoff AO, Marui S. Pre-operative role of BRAF in the guidance of the surgical approach and prognosis of differentiated thyroid carcinoma. Eur J Endocrinol. 2014;170(4):619–625. doi:10.1530/EJE-13-0944
   PubMed Web of Science ®Google Scholar
• Dong SY, Zeng RC, Jin LP, et al. BRAF(V600E) mutation is not associated with central lymph node metastasis in all patients with papillary thyroid cancer: different histological subtypes and preoperative lymph node status should be taken into account. Oncol Lett. 2017;14(4):4122–4134. doi:10.3892/ol.2017.6694
   PubMed Web of Science ®Google Scholar
• Zhou SL, Guo YP, Zhang L, et al. Predicting factors of central lymph node metastasis and BRAF(V600E) mutation in Chinese population with papillary thyroid carcinoma. World J Surg Oncol. 2021;19(1):211. doi:10.1186/s12957-021-02326-y
   PubMed Web of Science ®Google Scholar
• Akın Ş, Yazgan Aksoy D, Akın S, Kılıç M, Yetişir F, Bayraktar M. Prediction of central lymph node metastasis in patients with thyroid papillary microcarcinoma. Turk J Med Sci. 2017;47(6):1723–1727. doi:10.3906/sag-1702-99
   PubMed Web of Science ®Google Scholar
• Shi Y, Yang Z, Heng Y, Ju H, Pan Y, Zhang Y. Clinicopathological findings associated with cervical lymph node metastasis in papillary thyroid microcarcinoma: a retrospective study in China. Cancer Control. 2022;29:10732748221084926. doi:10.1177/10732748221084926
   Web of Science ®Google Scholar
• Yang Z, Heng Y, Qiu W, Tao L, Cai W. Cervical lymph node metastasis differences in patients with unilateral or bilateral papillary thyroid microcarcinoma: a multi-center analysis. J Clin Med. 2022;11(16):4929. doi:10.3390/jcm11164929
   PubMed Web of Science ®Google Scholar